Impact of COVID-19 on Lung Transplant Activity in Germany-A Cross-Sectional Survey.
Journal
The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
9
9
2020
medline:
4
3
2021
entrez:
8
9
2020
Statut:
ppublish
Résumé
The current COVID-19 pandemia affects health care systems worldwide, however, to a variable extent depending on the caseload in each country. We aimed to provide a cross-sectional overview of current limitations or adaptions in lung transplant programs in Germany in from January to May 2020 due to the COVID-19 pandemia caused by severe acute respiratory syndrome coronavirus 2. A cross-sectional survey assessing various aspects of lung transplant activity was sent to all active lung transplant programs (
Identifiants
pubmed: 32898894
doi: 10.1055/s-0040-1715436
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-94Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
Dr. Gottlieb reports grants from Breath Therapeutics, Gilead, Deutsche Forschungsgemeinschaft, and personal fees from Breath Therapeutics, outside the submitted work. All the other authors report no conflict of interest.